Published in Protein Sci on January 01, 1992
Localized solution structure refinement of an F45W variant of ubiquitin using stochastic boundary molecular dynamics and NMR distance restraints. Protein Sci (1995) 0.93
Crevice-forming mutants of bovine pancreatic trypsin inhibitor: stability changes and new hydrophobic surface. Protein Sci (1993) 0.92
Hydrogen exchange in BPTI variants that do not share a common disulfide bond. Protein Sci (1994) 0.79
Structures of DNA-binding mutant zinc finger domains: implications for DNA binding. Protein Sci (1993) 0.77
Leveraging reciprocity to identify and characterize unknown allosteric sites in protein tyrosine phosphatases. J Mol Biol (2017) 0.75
The anatomy and taxonomy of protein structure. Adv Protein Chem (1981) 16.85
Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. Biochem Biophys Res Commun (1983) 9.18
Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun (1983) 7.26
Sequential resonance assignments as a basis for determination of spatial protein structures by high resolution proton nuclear magnetic resonance. J Mol Biol (1982) 3.05
Kinetic role of a meta-stable native-like two-disulphide species in the folding transition of bovine pancreatic trypsin inhibitor. J Mol Biol (1984) 2.21
Genetic and structural analysis of the protein stability problem. Biochemistry (1987) 2.07
A peptide model of a protein folding intermediate. Nature (1988) 1.68
Structure of form III crystals of bovine pancreatic trypsin inhibitor. J Mol Biol (1987) 1.58
Kinetic analysis of the folding and unfolding of a mutant form of bovine pancreatic trypsin inhibitor lacking the cysteine-14 and -38 thiols. Biochemistry (1988) 1.20
Two-dimensional nuclear Overhauser effect: complete relaxation matrix analysis. Methods Enzymol (1989) 1.20
The sampling properties of some distance geometry algorithms applied to unconstrained polypeptide chains: a study of 1830 independently computed conformations. Biopolymers (1990) 1.12
Intermediates in the refolding of reduced pancreatic trypsin inhibitor. J Mol Biol (1974) 1.12
Protein structures from NMR. Biochemistry (1988) 1.11
Denaturant-dependent folding of bovine pancreatic trypsin inhibitor mutants with two intact disulfide bonds. Biochemistry (1990) 0.95
Heuristic refinement method for determination of solution structure of proteins from nuclear magnetic resonance data. Methods Enzymol (1989) 0.93
Reinvestigation of the aromatic side-chains in the basic pancreatic trypsin inhibitor by heteronuclear two-dimensional nuclear magnetic resonance. J Mol Biol (1987) 0.87
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
Complete sequence of bovine mitochondrial DNA. Conserved features of the mammalian mitochondrial genome. J Mol Biol (1982) 11.71
Shotgun DNA sequencing using cloned DNase I-generated fragments. Nucleic Acids Res (1981) 8.23
Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet (2000) 7.16
Hydration of proteins and polypeptides. Adv Protein Chem (1974) 6.25
Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst (1999) 5.92
A geometric approach to macromolecule-ligand interactions. J Mol Biol (1982) 5.71
Determinants and consequences of smoke-free homes: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 5.63
Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med (1995) 5.45
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1995) 5.27
A short primer for sequencing DNA cloned in the single-stranded phage vector M13mp2. Nucleic Acids Res (1980) 4.98
DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des (2001) 4.54
Distinctive sequence of human mitochondrial ribosomal RNA genes. Nature (1980) 4.30
Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens (1988) 3.86
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med (1989) 3.83
Different pattern of codon recognition by mammalian mitochondrial tRNAs. Proc Natl Acad Sci U S A (1980) 3.74
Complete mitochondrial genome sequences of two extinct moas clarify ratite evolution. Nature (2001) 3.12
Prescribing at the hospital-general practice interface. I: Hospital outpatient dispensing policies in England. BMJ (1992) 3.09
Cavities in proteins: structure of a metmyoglobin-xenon complex solved to 1.9 A. Biochemistry (1984) 3.05
Effects of the 2003 advertising/promotion ban in the United Kingdom on awareness of tobacco marketing: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 3.05
Counselling in general practice. J R Coll Gen Pract (1979) 2.99
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest (1985) 2.99
Implication of a novel multiprotein Dam1p complex in outer kinetochore function. J Cell Biol (2001) 2.98
High throughput protein fold identification by using experimental constraints derived from intramolecular cross-links and mass spectrometry. Proc Natl Acad Sci U S A (2000) 2.96
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
A mutant of Arabidopsis deficient in the chloroplast 16:1/18:1 desaturase. Plant Physiol (1989) 2.93
Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect (2004) 2.92
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest (1986) 2.91
Hydration of macromolecules. Science (1969) 2.88
Genetic Bit Analysis: a solid phase method for typing single nucleotide polymorphisms. Nucleic Acids Res (1994) 2.79
Involvement of DNA polymerase alpha in simian virus 40 DNA replication. J Biol Chem (1978) 2.74
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet (1991) 2.70
Impaired development of Th2 cells in IL-13-deficient mice. Immunity (1998) 2.68
The properties of water in biological systems. Annu Rev Biophys Bioeng (1974) 2.62
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med (1988) 2.61
Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A (1991) 2.55
Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet (1999) 2.42
Optical diffraction studies of muscle fibers. Biophys J (1973) 2.40
Should we adjust for covariates in nonlinear regression analyses of randomized trials? Control Clin Trials (1998) 2.40
High-level production of uniformly ¹⁵N- and ¹³C-enriched fusion proteins in Escherichia coli. J Biomol NMR (1996) 2.38
Hydration of macromolecules. IV. Polypeptide conformation in frozen solutions. J Am Chem Soc (1971) 2.34
Molecular cloning and nucleotide sequence of the streptavidin gene. Nucleic Acids Res (1986) 2.30
Thermal expansion of a protein. Biochemistry (1987) 2.25
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. J Med Chem (1988) 2.20
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18
Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood (2000) 2.16
Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst (2001) 2.12
Molecular models for DNA damaged by photoreaction. Science (1985) 2.05
The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet (1999) 2.02
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology (2010) 2.01
Protein folding. J Am Chem Soc (1972) 1.98
Isolation of a genomic clone for bovine pancreatic trypsin inhibitor by using a unique-sequence synthetic DNA probe. Proc Natl Acad Sci U S A (1983) 1.96
Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons. Neuron (2000) 1.91
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol (2001) 1.87
Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol (1989) 1.86
Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg (1994) 1.86
Protein docking and complementarity. J Mol Biol (1991) 1.86
Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc Natl Acad Sci U S A (1993) 1.82
Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry (2001) 1.81
Molecular docking to ensembles of protein structures. J Mol Biol (1997) 1.80
Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res (1994) 1.77
Case management quality assessment in rural areas of Papua New Guinea. Trop Doct (1995) 1.77
An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons. Neuron (1998) 1.76
Molecular dynamics simulations of d(C-G-C-G-A) X d(T-C-G-C-G) with and without "hydrated" counterions. Proc Natl Acad Sci U S A (1985) 1.76
Spin labeling of proteins. Methods Enzymol (1989) 1.75
Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer (1993) 1.70
Mutational and secondary structural analysis of the basolateral sorting signal of the polymeric immunoglobulin receptor. J Cell Biol (1993) 1.68
Ligand solvation in molecular docking. Proteins (1999) 1.65
Turn prediction in proteins using a pattern-matching approach. Biochemistry (1986) 1.65
Determinations of atomic partial charges for nucleic acid constituents from x-ray diffraction data. I. 2'-Deoxycytidine-5'-monophosphate. Biopolymers (1985) 1.64
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest (1992) 1.63
Metabolism of Okazaki fragments during simian virus 40 DNA replication. J Biol Chem (1979) 1.62
Structure-based discovery of inhibitors of thymidylate synthase. Science (1993) 1.61
Close linkage of c-Harvey-ras-1 and the insulin gene to affective disorder is ruled out in three North American pedigrees. Nature (1987) 1.61
Assignment of segments of the bacteriorhodopsin sequence to positions in the structural map. Biophys J (1983) 1.58
Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci U S A (1995) 1.58
Immobilization of oligonucleotides onto a glass support via disulfide bonds: A method for preparation of DNA microarrays. Anal Biochem (1999) 1.58
MARCKS regulates membrane ruffling and cell spreading. Curr Biol (1997) 1.56
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. J Clin Oncol (1997) 1.56
Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol (1986) 1.54
Matching chemistry and shape in molecular docking. Protein Eng (1993) 1.53
Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions. Ann Intern Med (1989) 1.53
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Production of 2-Keto-L-Gulonate, an Intermediate in L-Ascorbate Synthesis, by a Genetically Modified Erwinia herbicola. Science (1985) 1.52
Synthesis of the small subunit of ribulose-bisphosphate carboxylase from genes cloned into plasmids containing the SP6 promoter. Biochem J (1986) 1.52
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52
Initial description of the human NLRP3 promoter. Genes Immun (2008) 1.52
Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry (1993) 1.51
Assessment of fat malabsorption. J Clin Pathol (1983) 1.49
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol (1997) 1.48
Molecular docking programs successfully predict the binding of a beta-lactamase inhibitory protein to TEM-1 beta-lactamase. Nat Struct Biol (1996) 1.48
A molecular dynamics simulation of polyalanine: an analysis of equilibrium motions and helix-coil transitions. Biopolymers (1991) 1.47
A molecular dynamics simulation of double-helical B-DNA including counterions and water. Proc Natl Acad Sci U S A (1985) 1.47
Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proc Natl Acad Sci U S A (1990) 1.46